Malarial hepatitis is a condition where a patient who is suffering from severe malaria, meaning one or more complication is present which includes hepatic dysfunction. Jaundice is the commonest sign of malarial hepatitis as well as alteration in liver function but malarial hepatitis is indicated by a rise in serum glutamate pyruvate transaminase levels to more than three times the upper limit of normal and an absence of clinical or serological evidence to suggest drug or viral hepatitis. Malarial hepatitis is most commonly seen in males at the average age of 27.6 years. Prevention to malarial hepatitis is taking measures to prevent malaria when in areas of high risk.
Malarial Hepatitis Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Malarial Hepatitis below!
For more information on how to use Laverne, please read the How to Guide.
We have 310 products for the study of Malarial Hepatitis that can be applied to Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.